| Christopher Hein, | |
|
450 E 23rd St, Fremont, NE 68025-2303 | |
| (402) 727-3751 | |
| Not Available |
| Full Name | Christopher Hein |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 450 E 23rd St, Fremont, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285005413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12778 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Hein, 450 E 23rd St, Fremont, NE 68025-2303 Ph: (402) 727-3751 | Christopher Hein, 450 E 23rd St, Fremont, NE 68025-2303 Ph: (402) 727-3751 |
News Archive
Researchers at the University of Maryland School of Medicine have identified a common gene variant that appears to influence people's risk of developing high blood pressure, according to the results of a study being published online Dec. 29, 2008 in the Proceedings of the National Academy of Sciences (PNAS).
Research led by Michael J. Hannon from the University of Birmingham, UK, finds metallo-supramolecular helicates (cylinders) binding to untranslated regions of SARS-CoV-2 suppresses viral replication. The untranslated regions (UTR) of the viral genome could serve as drug targets for antiviral treatment.
Archer Daniels Midland Company and Rennovia, Inc. announced today that ADM has committed to a $25 million equity investment in the privately held company, which develops catalysts and processes for the cost-advantaged production of chemical products from renewable feedstocks.
Departing the workforce entirely and entering retirement at age 65 is no longer a reality for many older people in the United States, according to a recent survey by The Associated Press-NORC Center for Public Affairs Research.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 5 days ago
Dr. Stephanie Lynn Meyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 | |
Dominic Tang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1531 N Bell St, Fremont, NE 68025 Phone: 402-727-1995 Fax: 402-753-0073 | |
Annette Seely, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1531 N Bell St, Fremont, NE 68025 Phone: 402-727-1995 Fax: 402-753-0073 | |
Aaron Stalets, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 Fax: 402-721-0785 | |
Mrs. Christy Lynn Piti, B.S., R.P. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 224 N Park Ave, Fremont, NE 68025 Phone: 402-753-2800 Fax: 402-753-2863 | |
Mrs. Amy Mcmurtry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1525 E 23rd St, Fremont, NE 68025 Phone: 402-721-8872 | |
Craig Morgan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-7266 |